@article {Park363549, author = {Ki-Ho Park and Dong Youn Kim and Yu-Mi Lee and Mi Suk Lee and Kyung-Chung Kang and Jung Hee Lee and Seong Yeon Park and Chisook Moon and Yong Pil Chong and Sung-Han Kim and Sang-Oh Lee and Sang-Ho Choi and Yang Soo Kim and Jun Hee Woo and In-Gyu Bae and Oh-Hyun Cho}, title = {Selection of an Appropriate Empiric Antibiotic Regimen in Culture-Negative Hematogenous Vertebral Osteomyelitis}, elocation-id = {363549}, year = {2018}, doi = {10.1101/363549}, publisher = {Cold Spring Harbor Laboratory}, abstract = {The aim of this study was to determine which antibiotic combinations are appropriate for culture-negative hematogenous vertebral osteomyelitis (HVO), based on the antibiotic-susceptibility pattern of organisms isolated from cases of culture-proven HVO. We conducted a retrospective chart review of adult patients with microbiologically proven HVO in five tertiary-care hospitals over a 7-year period. The appropriateness of empiric antibiotic regimens was assessed based on the antibiotic susceptibility profiles of isolated bacteria. In total, 358 cases of microbiologically proven HVO were identified. The main causative pathogens identified were methicillin-susceptible Staphylococcus aureus (33.5\%), followed by methicillin-resistant S. aureus (MRSA) (24.9\%), aerobic gram-negative bacteria (21.8\%), and Streptococcus species (11.7\%). Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae and anaerobes accounted for only 1.7\% and 1.4\%, respectively, of the causative pathogens. Based on the susceptibility results of isolated organisms, levofloxacin plus rifampicin was appropriate in 73.5\%, levofloxacin plus clindamycin in 71.2\%, and amoxicillin-clavulanate plus ciprofloxacin in 64.5\% of cases. These oral combinations were more appropriate for treating community-acquired HVO (85.8\%, 84.0\%, and 80.4\%, respectively) than healthcare-associated HVO (52.6\%, 49.6\%, and 37.6\%, respectively). Vancomycin combined with ciprofloxacin, ceftriaxone, ceftazidime, or cefepime was similarly appropriate (susceptibility rates of 93.0\%, 94.1\%, 95.8\%, and 95.8\%, respectively). In conclusion, in a setting with a high prevalence of MRSA HVO, oral antibiotic combinations may be suboptimal for treatment of culture-negative HVO and should be used only in patients with community-acquired HVO. Vancomycin combined with fluoroquinolone or a broad-spectrum cephalosporin was appropriate in most cases of HVO in this study.}, URL = {https://www.biorxiv.org/content/early/2018/07/11/363549}, eprint = {https://www.biorxiv.org/content/early/2018/07/11/363549.full.pdf}, journal = {bioRxiv} }